Separating promise from proof One of the biggest misconceptions surrounding BPC-157 is that its popularity reflects a strong body of clinical evidence
Clinical overview of semaglutide safety and efficacy
doi: 10.1016/j.bbadis.2016.08.018 215 PugazhenthiSQinLReddyH
Documented by Freedom Diagnostics, an independent lab you can look up
No, at controlled dosages, reported effects are typically mild such as temporary muscle tightness or water retention and are reversible under appropriate medical oversight
GLP-1 receptor agonists exert neuroprotective effects primarily by inhibiting microglial activation, the primary effector cells of neuroinflammation, thus reducing the production of proinflammatory cytokines (e.g., TNF- , IL-1) and alleviating inflammatory damage to brain parenchyma